Please assess the completion status of the following clinical trial:

Trial Title: Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: At least 2 years (at time of obtaining informed consent)~* Diagnosis of AD based on the Japanese Dermatological Association's criteria~* Atopic dermatitis affecting ≥5% of body surface area (BSA, excluding scalp) at the screening and baseline examinations~Exclusion Criteria:~- Subjects who have an AD or contact dermatitis flare-up defined as a rapid intensification of AD, within 28 days prior to the baseline examination

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 0.3% OPA-15406 ointment (Type: EXPERIMENTAL): Twice daily
- 1% OPA-15406 ointment (Type: EXPERIMENTAL): Twice daily

Based on this trial design, predict the completion outcome and termination type (if applicable).